首页 | 本学科首页   官方微博 | 高级检索  
     

米非司酮联合双侧子宫动脉灌注甲氨蝶呤治疗剖宫产瘢痕妊娠临床评价
引用本文:李英,范玖香,崔雪娇. 米非司酮联合双侧子宫动脉灌注甲氨蝶呤治疗剖宫产瘢痕妊娠临床评价[J]. 中国药业, 2021, 0(8): 58-60
作者姓名:李英  范玖香  崔雪娇
作者单位:秦皇岛军工医院;河北港口集团有限公司港口医院
基金项目:河北省医学科学研究课题[20201309]。
摘    要:目的 研究米非司酮联合双侧子宫动脉灌注甲氨蝶呤(MTX)治疗剖宫产瘢痕妊娠(CSP)的临床疗效,以及对血β-人绒毛膜促性腺激素(β-HCG)水平的影响.方法 选取秦皇岛军工医院2018年1月至2019年1月收治的CSP患者74例,按随机数字表法分为对照组和治疗组,各37例.两组患者均口服米非司酮片,并超声引导下清宫,治...

关 键 词:剖宫产瘢痕妊娠  米非司酮  双侧子宫动脉灌注  甲氨蝶呤  β-人绒毛膜促性腺激素

Efficacy Evaluation of Mifepristone Combined with Bilateral Uterine Artery Infusion of Methotrexate in the Treatment of Patients with Cesarean Scar Pregnancy
LI Ying,FAN Jiuxiang,CUI Xuejiao. Efficacy Evaluation of Mifepristone Combined with Bilateral Uterine Artery Infusion of Methotrexate in the Treatment of Patients with Cesarean Scar Pregnancy[J]. China Pharmaceuticals, 2021, 0(8): 58-60
Authors:LI Ying  FAN Jiuxiang  CUI Xuejiao
Affiliation:(Qinhuangdao Military Hospital,Hebei,China 066000;Port Hospital of Hebei Port Group Co.,Ltd.,Hebei,China 066000)
Abstract:Objective To study the clinical efficacy of mifepristone combined with bilateral uterine artery infusion of methotrexate(MTX)in the treatment of patients with cesarean scar pregnancy(CSP),and the effect on the level of serum human chorionic gonadotropinβ(β-HCG).Methods A total of 74 patients with CSP admitted to the Qinhuangdao Military Hospital were selected and divided into the control group and the treatment group according to the random number table method,37 cases in each group.The patients in the two groups were given the oral treatment of Mifepristone Tablets and ultrasound-guided uterine clearance,on this basis,the patients in the treatment group were treated with bilateral uterine artery perfusion of MTX.Results The effective rate of the treatment group was91.89%,which was significantly higher than 67.57%of the control group(P<0.05).The time of curettage,the time ofβ-HCG turning negative,the time of gestational sac disappearing,the time of menstrual recovery and the length of stay in the treatment group were significantly shorter than those in the control group(P<0.05).The level ofβ-HCG in the treatment group was significantly lower than that in the control group,while the levels of progesterone,estradiol,luteinizing hormone and follicle-stimulating hormone in the treatment group were significantly higher than those in the control group(P<0.05).The incidence of adverse reactions in the treatment group was 5.41%,which was significantly lower than 24.32%in the control group(P<0.05).Conclusion Mifepristone combined with bilateral uterine artery infusion of MTX in the treatment of patients with CSP can shorten the time of curettage andβ-HCG turning negative,improve the level ofβ-HCG,and has no obvious adverse effect on the level of sex hormone.
Keywords:cesarean scar pregnancy  mifepristone  bilateral uterine artery infusion  methotrexate  human chorionic gonadotropinβ
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号